BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,037 filers reported holding BAXTER INTL INC in Q1 2015. The put-call ratio across all filers is 0.65 and the average weighting 0.4%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $667,000 | +0.3% | 14,754 | -8.9% | 0.62% | +2.8% |
| Q1 2016 | $665,000 | -9.5% | 16,200 | -15.9% | 0.61% | +5.7% |
| Q4 2015 | $735,000 | -2.6% | 19,255 | -16.2% | 0.58% | -5.0% |
| Q3 2015 | $755,000 | -52.3% | 22,970 | +1.4% | 0.60% | -44.0% |
| Q2 2015 | $1,584,000 | +30.2% | 22,645 | +27.4% | 1.08% | +18.9% |
| Q1 2015 | $1,217,000 | -34.1% | 17,770 | -29.5% | 0.91% | -8.7% |
| Q4 2014 | $1,848,000 | -4.2% | 25,210 | -6.2% | 1.00% | -3.9% |
| Q3 2014 | $1,929,000 | -3.7% | 26,876 | -3.0% | 1.04% | +3.8% |
| Q2 2014 | $2,003,000 | -2.6% | 27,706 | -0.8% | 1.00% | -8.5% |
| Q1 2014 | $2,056,000 | +8.0% | 27,936 | +2.1% | 1.09% | +5.4% |
| Q4 2013 | $1,903,000 | -3.5% | 27,361 | -8.8% | 1.03% | -7.4% |
| Q3 2013 | $1,971,000 | -9.2% | 30,006 | -4.3% | 1.12% | -8.8% |
| Q2 2013 | $2,171,000 | – | 31,341 | – | 1.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |